**Core Concept**
Familial hemolytic uremic syndromes (HUS) are a group of disorders characterized by the triad of hemolytic anemia, acute kidney injury, and thrombocytopenia. These conditions are often caused by mutations in genes involved in the complement system, leading to uncontrolled activation and damage to the endothelium.

**Why the Correct Answer is Right**
Familial HUS typically presents with microangiopathic hemolytic anemia, characterized by the presence of schistocytes and elevated lactate dehydrogenase (LDH) levels. Renal involvement is marked by acute kidney injury, often requiring dialysis, and thrombocytopenia is a common feature. The complement system, particularly the alternative pathway, plays a crucial role in the pathogenesis of familial HUS.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not accurately describe a feature of familial HUS.
**Option B:** This option is incorrect as it does not accurately describe a feature of familial HUS.
**Option C:** This option is incorrect as it does not accurately describe a feature of familial HUS.

**Clinical Pearl / High-Yield Fact**
In familial HUS, early recognition and treatment with eculizumab, a complement inhibitor, can significantly improve outcomes and reduce the risk of long-term kidney damage.

**Correct Answer:** Not Provided.